Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Linking SOX10 to a slow-growth resistance phenotype.

Cell research - 1 Aug 2014

Zhang Gao, Herlyn Meenhard

Abstract excerpt

Slow-cycling BRAF melanoma cells are notoriously resistant to standard chemotherapy or targeted therapy but the underlying mechanism remains elusive. Now a new study unlocks this mystery and offers novel insights into developing more effective therapeutic interventions.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Indoles
Share to Melanoma
Share to Microphthalmia-Associated Transcription Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA Interference

Share to RNA, Small Interfering

Share to SOXE Transcription Factors

Share to Sulfonamides

Share to Vemurafenib

Source

Open in PubMed Open full text

Identifiers

PMID: 24853952
DOI: 10.1038/cr.2014.67
PMCID: PMC4123291

Genes

BRAF
SOX10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Linking SOX10 to a slow-growth resistance phenotype.PMID 24853952Read ↗

The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma.Semantic proximity Read ↗

Specific <i>SOX10</i> enhancer elements modulate phenotype plasticity and drug resistance in melanomaSemantic proximity Read ↗

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.Semantic proximity Read ↗

Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomasSemantic proximity Read ↗

Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in MelanomaSemantic proximity Read ↗

SOX2 empowers a rapid tumorigenic programme from the tumour-resistant population in the skinSemantic proximity Read ↗

SOX10 and microRNAs: decoding their interplay in regulating melanoma plasticitySemantic proximity Read ↗

SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.Semantic proximity Read ↗

Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.Semantic proximity Read ↗

Differential Gene Expression Common to Acquired and Intrinsic Resistance to BRAF Inhibitor Revealed by RNA-Seq AnalysisSemantic proximity Read ↗

p300 KAT regulates SOX10 stability and function in human melanomaSemantic proximity Read ↗

ZNF667‐AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressivenessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.